No benefit of combination immunotherapy in treatment of advanced cancers: Study
Combination immunotherapy shows no additional benefit for most advanced cancers other than skin cancer, a new study has found. According to the study published in the journal JAMA Oncology, the combination immunotherapy treatment of nivolumab plus ipilimumab, a targeted therapy drug, was